Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | GPR27 | Q9NS67 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | SLC16A3 | O15427 | 3/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12010908 | 0.84 | GAA (0.66) | MAPTNPC1RAB9ACA2GAA | |
| SCHEMBL7770159 | 0.82 | LMNA (0.64) | MAPTNPC1RAB9ACA2GAA | |
| SCHEMBL17103006 | 0.81 | MEN1 (0.64) | MAPTCA2GAAGPR27LMNA | |
| SCHEMBL15145840 | 0.81 | LMNA (0.70) | MAPTCA2GAALMNAMEN1 | |
| SCHEMBL6077413 | 0.81 | NPC1 (0.62) | MAPTNPC1RAB9ACA2GAA | |
| SCHEMBL17103024 | 0.81 | TUBB4A (0.60) | MAPTNPC1RAB9AGAALMNA | |
| SCHEMBL17103025 | 0.81 | MEN1 (0.63) | MAPTNPC1RAB9ACA2GAA | |
| SCHEMBL20568030 | 0.80 | LMNA (0.61) | MAPTGAALMNAMEN1KMT2A | |
| SCHEMBL29895854 | 0.80 | LMNA (0.61) | MAPTGAALMNAMEN1KMT2A | |
| SCHEMBL17103022 | 0.80 | KMT2A (0.67) | MAPTNPC1RAB9AGAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2923851-B1 | RECORDING MATERIAL PRODUCED USING NON-PHENOL COMPOUND | NIPPON SODA CO (JP) | 2019-05-01 | — | — | EP | disclosed |
| US-9518011-B2 | Recording material produced using non-phenol compound | NIPPON SODA CO., LTD. (JP) | 2016-12-13 | — | — | US | disclosed |
| US-9518011-B2 | Recording material produced using non-phenol compound | NIPPON SODA CO., LTD. (JP) | 2016-12-13 | — | — | US | disclosed |
| US-20150284321-A1 | RECORDING MATERIAL PRODUCED USING NON-PHENOL COMPOUND | NIPPON SODA CO., LTD. (JP) | 2015-10-08 | — | — | US | disclosed |
| US-20150284321-A1 | RECORDING MATERIAL PRODUCED USING NON-PHENOL COMPOUND | NIPPON SODA CO., LTD. (JP) | 2015-10-08 | — | — | US | disclosed |
| EP-2923851-A1 | RECORDING MATERIAL PRODUCED USING NON-PHENOL COMPOUND | Nippon Soda Co., Ltd. (JP) | 2015-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150284321-A1 | RECORDING MATERIAL PRODUCED USING NON-PHENOL COMPOUND | CYP19A1, ALPG, ALPP | MAPT 3343/4885NPC1 2944/4885RAB9A 1790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.